| Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells E Haythorne, M Rohm, M van de Bunt, MF Brereton, AI Tarasov, ... Nature communications 10 (1), 2474, 2019 | 272 | 2019 |
| Adipose tissue: between the extremes A Vegiopoulos, M Rohm, S Herzig The EMBO journal 36 (14), 1999-2017, 2017 | 247 | 2017 |
| Cancer cachexia: more than skeletal muscle wasting SF Schmidt, M Rohm, S Herzig, MB Diaz Trends in cancer 4 (12), 849-860, 2018 | 173 | 2018 |
| Energy metabolism in cachexia M Rohm, A Zeigerer, J Machado, S Herzig EMBO reports 20 (4), e47258, 2019 | 140 | 2019 |
| Is type 2 diabetes a glycogen storage disease of pancreatic β cells? FM Ashcroft, M Rohm, A Clark, MF Brereton Cell metabolism 26 (1), 17-23, 2017 | 125 | 2017 |
| An AMP-activated protein kinase–stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice M Rohm, M Schäfer, V Laurent, BE Üstünel, K Niopek, C Algire, ... Nature medicine 22 (10), 1120-1130, 2016 | 124 | 2016 |
| Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells MF Brereton, M Rohm, K Shimomura, C Holland, S Tornovsky-Babeay, ... Nature communications 7 (1), 13496, 2016 | 119 | 2016 |
| TSC22D4 is a molecular output of hepatic wasting metabolism A Jones, K Friedrich, M Rohm, M Schäfer, C Algire, P Kulozik, O Seibert, ... EMBO molecular medicine 5 (2), 294-308, 2013 | 89 | 2013 |
| β‐Cell dysfunction in diabetes: a crisis of identity? MF Brereton, M Rohm, FM Ashcroft Diabetes, obesity and metabolism 18, 102-109, 2016 | 80 | 2016 |
| Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia M Schäfer, CU Oeing, M Rohm, E Baysal-Temel, LH Lehmann, R Bauer, ... Molecular metabolism 5 (2), 67-78, 2016 | 64 | 2016 |
| Control of adipose tissue inflammation through TRB1 A Ostertag, A Jones, AJ Rose, M Liebert, S Kleinsorg, A Reimann, ... Diabetes 59 (8), 1991-2000, 2010 | 62 | 2010 |
| Transcriptional cofactor TBLR1 controls lipid mobilization in white adipose tissue M Rohm, A Sommerfeld, D Strzoda, A Jones, TP Sijmonsma, G Rudofsky, ... Cell metabolism 17 (4), 575-585, 2013 | 52 | 2013 |
| Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic β-cells E Haythorne, M Lloyd, J Walsby-Tickle, AI Tarasov, J Sandbrink, I Portillo, ... Nature Communications 13 (1), 6754, 2022 | 39 | 2022 |
| High levels of modified ceramides are a defining feature of murine and human cancer cachexia P Morigny, J Zuber, M Haid, D Kaltenecker, F Riols, JDC Lima, E Simoes, ... Journal of cachexia, sarcopenia and muscle 11 (6), 1459-1475, 2020 | 37 | 2020 |
| De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry VM Prade, T Kunzke, A Feuchtinger, M Rohm, B Luber, F Lordick, A Buck, ... Molecular metabolism 36, 100953, 2020 | 36 | 2020 |
| Cardiac dysfunction and metabolic inflexibility in a mouse model of diabetes without dyslipidemia M Rohm, D Savic, V Ball, MK Curtis, S Bonham, R Fischer, N Legrave, ... Diabetes 67 (6), 1057-1067, 2018 | 35 | 2018 |
| Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy P Morigny, D Kaltenecker, J Zuber, J Machado, L Mehr, FF Tsokanos, ... Journal of cachexia, sarcopenia and muscle 12 (5), 1333-1351, 2021 | 17 | 2021 |
| Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases NS Pellegata, M Berriel Diaz, M Rohm, S Herzig Cancer and Metastasis Reviews 41 (3), 517-547, 2022 | 12 | 2022 |
| Aging aggravates cachexia in tumor-bearing mice J Geppert, AA Walth, RT Expósito, D Kaltenecker, P Morigny, J Machado, ... Cancers 14 (1), 90, 2021 | 10 | 2021 |
| TBL1XR1 ensures balanced neural development through NCOR complex-mediated regulation of the MAPK pathway G Mastrototaro, M Zaghi, L Massimino, M Moneta, N Mohammadi, F Banfi, ... Frontiers in Cell and Developmental Biology 9, 641410, 2021 | 9 | 2021 |
